Cantitate/Preț
Produs

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Advances in Immunology, cartea 165

Arun Kumar Singh, Neeraj Mishra, Sumel Ashique, Pranav Kumar Prabhakar
en Limba Engleză Hardback – mai 2025
Advances in Immunology, Volume 165, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.

  • Presents current developments and comprehensive reviews in immunology
  • Provides the latest in a longstanding and respected serial on the subject matter
  • Focuses on recent advances in the field of immunology
Citește tot Restrânge

Din seria Advances in Immunology

Preț: 81786 lei

Preț vechi: 109058 lei
-25% Nou

Puncte Express: 1227

Preț estimativ în valută:
15653 16279$ 13098£

Carte nepublicată încă

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443344954
ISBN-10: 0443344957
Pagini: 198
Dimensiuni: 152 x 229 mm
Editura: ELSEVIER SCIENCE
Seria Advances in Immunology


Cuprins

1. DNA and mRNA vaccines: Significant therapeutic approach against cancer management.
2. Nanoparticles for mRNA-based cancer immunotherapy
3. Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy
4. Plasmid DNA and mRNA: Delivery approaches and challenges
5. Viral & Non-viral Delivery of mRNA against Cancer Cell
6. Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy
7. mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment
8. Therapeutic mRNAs for cancer immunotherapy: from structure to delivery
9. Harnessing the immune system: Insights into cancer vaccines
10. Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy
11. Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment
12. Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy
13. Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development
14. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA and mRNA Vaccine in cancer Immunotherapy